Optimizing Outcomes with Remote Monitoring: Expert Perspectives-Optimizing Outcomes with Remote Monitoring: Expert Perspectives

Video Transcription

Video Summary

The webinar, moderated by Dr. Michael Zile, focused on optimizing heart failure outcomes with remote pulmonary artery (PA) pressure monitoring. Experts discussed the two FDA/CMS-approved devices, CardioMEMS and Cordella, their different indications, and the evidence supporting them through randomized trials, observational studies, and meta-analyses. Panelists emphasized that PA pressures can predict worsening heart failure across the full range of ejection fractions and that monitoring supports proactive, earlier intervention. Workflow was highlighted as essential for success, especially in the first 90 days after implant, with frequent pressure review and medication adjustments. Most treatment changes involved diuretics, though guideline-directed medical therapy and lifestyle behaviors also affected pressures. The panel also discussed use during hospitalizations, noting that elevated pressures after non-heart-failure admissions can predict early readmission. Overall, the group agreed that remote hemodynamic monitoring improves heart failure hospitalizations, quality of life, and care coordination.

Keywords

heart failure

pulmonary artery pressure monitoring

CardioMEMS

Cordella

remote hemodynamic monitoring

hospitalization reduction

CardioMEMS

Cordella Pulmonary Artery Sensor System

Implantable Pulmonary Artery Pressure Remote Hemodynamic Monitoring

Heart Failure

Hospitalization